Literature DB >> 8503412

Angiotensin II local hyperreactivity in the progression of IgA nephropathy.

R Coppo1, A Amore, B Gianoglio, G Cacace, G Picciotto, D Roccatello, L Peruzzi, G Piccoli, P G De Filippi.   

Abstract

Immunologic and hemodynamic factors are likely to work in synergism in the progression of immunoglobulin A nephropathy (IgAN) toward sclerosis. The local activation of the renin-angiotensin system may be one the most relevant mechanisms. We investigated the hemodynamic effects of the acute administration of angiotensin-converting enzyme inhibitor (ACEI) (captopril 50 mg). The glomerular filtration rate (GFR) and the effective renal plasma flow (ERPF) were measured by 51Cr-EDTA and 125I hippurate clearances. The correspondent filtration fractions (FFs) in basal conditions and after administration of ACEI were calculated, then the changes in FF (delta FF and % delta FF) were determined. We studied 27 IgAN patients. Eighteen patients had normal renal function (GFR, 112 +/- 19 mL/min/1.73 m2) and nine had moderate renal impairment (GFR, 54 +/- 13 mL/min/1.73 m2). Sixteen patients had proteinuria > or = 0.5 g/d. In addition, 12 glomerulonephritis control cases and eight healthy subjects were investigated. After the administration of ACEI in healthy subjects we observed slight modifications in the GFR, a significant increase in the ERPF (P < 0.005), and a significant decrease in FF (P < 0.04). Similarly, in IgAN patients with normal renal function the GFR increased slightly, the ERPF increased significantly (P < 0.01), and there was a decrease in FF (P < 0.01). The delta FF and % delta FF values were not significantly different from those found in the controls. In patients with initial renal failure GFR remained unchanged, ERPF increased significantly (P < 0.005), and FF significantly decreased (P < 0.004). However, the changes in delta FF and % delta FF were significantly greater than those found in healthy controls (P < 0.01) and in IgAN patients with normal renal function (P < 0.001). IgAN patients with proteinuria levels > or = 0.5 g/d showed greater changes in delta FF and % delta FF after the administration of ACEI than patients with proteinuria levels lower than 0.5 g/d (P < 0.003 and P < 0.04, respectively) or proteinuric control cases (P < 0.05 and P < 0.01, respectively). This different response in proteinuric and nonproteinuric patients was evident even when the analysis was limited to the subgroup of IgAN patients with normal renal function. The decrease in FF consequent to an increase in the ERPF after the administration of ACEI suggests a local hyperactivity of the renin-angiotensin system in some cases of IgAN.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503412     DOI: 10.1016/s0272-6386(12)80031-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients.

Authors:  Y Pei; J Scholey; K Thai; M Suzuki; D Cattran
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 2.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

3.  Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.

Authors:  Akira Nishiyama; Yoshio Konishi; Naro Ohashi; Takashi Morikawa; Maki Urushihara; Isseki Maeda; Masahiro Hamada; Masatsugu Kishida; Hirofumi Hitomi; Nobuo Shirahashi; Hiroyuki Kobori; Masahito Imanishi
Journal:  Nephrol Dial Transplant       Date:  2010-07-07       Impact factor: 5.992

4.  Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.

Authors:  Yan-Jie Huang; Xiao-Qing Yang; Wen-Sheng Zhai; Xian-Qing Ren; Qing-Yin Guo; Xia Zhang; Meng Yang; Tatsuo Yamamoto; Yuan Sun; Ying Ding
Journal:  World J Pediatr       Date:  2014-11-20       Impact factor: 2.764

5.  A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy.

Authors:  Koichi Nakanishi; Mayumi Sako; Nahoko Yata; Noriyuki Aoyagi; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2003-11-28       Impact factor: 3.714

Review 6.  New therapeutic perspectives for IgA nephropathy in children.

Authors:  Alexandra Cambier; Patrick J Gleeson; Héloise Flament; Marie-Bénédicte Le Stang; Renato C Monteiro
Journal:  Pediatr Nephrol       Date:  2020-02-10       Impact factor: 3.714

7.  Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.

Authors:  Joseph C K Leung; Loretta Y Y Chan; Sydney C W Tang; Man-Fai Lam; Chui-Wa Chow; Ai-Ing Lim; Kar-Neng Lai
Journal:  J Transl Med       Date:  2011-10-06       Impact factor: 5.531

8.  Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features.

Authors:  Alexandra Cambier; Marion Rabant; Michel Peuchmaur; Alexandre Hertig; Georges Deschenes; Cecile Couchoud; Anne Kolko; Remi Salomon; Julien Hogan; Thomas Robert
Journal:  Kidney Int Rep       Date:  2018-03-29

9.  Decreased expression of transforming growth factor-β1 and α-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats.

Authors:  Qingfei Xiao; Yinghui Guan; Chenhao Li; Li Liu; Dan Zhao; Hongyue Wang
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.